This conference will explore the latest developments in machine learning as they apply to enhancing drug discovery pipelines. It will feature case studies from leading pharma and biotech companies and a discussion of the shift from a situation where industry was faced with undruggable targets to new opportunities.
News - Events
This meeting is an opportunity to hear industry experts discuss the latest developments in parallel trade. Parallel trade is a type of commerce in which wholesales can buy medicinal products in one member state of the European Union, where prices are low, and sell the same products in another member state, where prices are higher. This form of arbitrage has been declared legal by the European Court of Justice.
This is a digital event.
The fifteenth annual BIO-Europe Spring springtime partnering conference will be held from 22 to 25 March in a fully digital format. It will include access to company presentations, programme sessions and sponsor and showcase company content up to five weeks prior to the live event.
This event will bring together specialists within the industry for prefilled syringes to discuss regulation, new digital technologies, human studies and delivery.
This virtual conference, directed at microbiologists, will discuss contamination control strategies for microbial products which are products derived from microscopic organisms. Microorganisms are used for the production of important substances such as antibiotics. The meeting will cover regulation, compliance and procedures for monitoring the impact of this activity on the environment.
This meeting will enable delegates to explore new drug discovery science and clinical developments in the field of pain therapeutics. Experts will lead a discussion about ways to approach the challenges of clinical trial design and conduct.
This year's event will focus on four themes relating to the management of highly potent active pharmaceutical ingredients. These are: best practice for toxicological assessment; innovations in containment and facility design; advances in the use of robotics and automation in the manufacturing process; and environmental considerations.
This two-day conference will bring together representatives of the pharmaceutical and biotechnology industries and academic institutions to provide first-hand information on the latest oligonucleotide clinical candidates. It will also act as a platform for exchanging ideas on one of the biggest challenges facing the industry: how to deliver these new therapies.
The aseptic processing industry, or the processing and packaging of a sterile product, has seen many changes. These are due to advances in manufacturing technology and the use of robotics and automation, to name a few aspects. In 2018, the global aseptic processing market was valued at more than $56 trillion. Revenue is expected to increase to around $124 trillion by 2027. The industry continues to adapt to innovative therapies and to demands to deliver treatments to patients faster. This meeting will examine the new technologies and how they will affect the industry.
This meeting will provide new information on the potential connectivity and software for medical devices and how these devices can be worn during clinical trials. Key regulatory updates and guidance will also be presented by regulatory, notified body and industry experts. The meeting will give a comprehensive outlook for this expanding field.